Humana AB (publ) (STO:HUM)
Sweden · Delayed Price · Currency is SEK 69.80
-0.40 (-0.57%)
Sep 4, 2026, 5:29 PM CET
Humana AB Market Cap
Humana AB has a market cap or net worth of 3.32 billion as of September 4, 2026. Its market cap has increased by 66.38% in one year.
Market Cap
3.32B
Enterprise Value
7.46B
Revenue
10.04B
Ranking
n/a
PE Ratio
19.34
Stock Price
69.80
ChartMarket Cap Chart
Since March 22, 2016, Humana AB's market cap has decreased from 3.40B to 3.32B, a decrease of -2.31%. That is a compound annual growth rate of -0.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 3.32B | 33.73% |
| Dec 30, 2025 | 2.48B | 34.25% |
| Dec 30, 2024 | 1.85B | 37.23% |
| Dec 29, 2023 | 1.35B | -26.88% |
| Dec 30, 2022 | 1.84B | -48.20% |
| Dec 30, 2021 | 3.55B | 18.94% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 158.02B |
| Getinge AB | 66.73B |
| Sectra AB | 55.18B |
| Medicover AB | 37.08B |
| RaySearch Laboratories AB | 5.92B |
| Hansa Biopharma AB | 4.75B |
| CellaVision AB | 3.88B |
| Egetis Therapeutics AB | 3.61B |